Association of Aldosterone, Renin, and Aldosterone to Renin Ratio with Metabolic Profile in Primary Aldosteronism

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2024 May 23

PMID 38778907

Authors

Minmin Han

Xiaoming Cao

Jian Zhang

XiFeng Yang

Yi Zhang

Yunfeng Liu

Affiliations

Soon will be listed here.

Abstract

Purpose: This study aimed to investigate the glycometabolism, fat mass, and lean mass in primary aldosteronism (PA) during disease progression.

Patients And Methods: Patients diagnosed with PA and healthy controls (HCs) were enrolled. A flash glucose monitoring system (FGMS) and dual-energy X-ray absorptiometry (DEXA) were used to measure glucose variability and glucose target rate along with fat mass and lean mass. Comparative analysis of FGMS- or DEXA-derived parameters along with correlation analyses between these parameters and PA progression were performed.

Results: Increased glucose variability and poor glucose target rate, along with an increased proportion of truncal fat mass, and decreased proportion of appendicular lean mass, were identified in PA group compared to those in HCs. Plasma aldosterone concentration was positively correlated with glucose variability and poor glucose target rate. Plasma renin concentration was positively correlated with the proportion of truncal fat mass and lean mass, and negatively correlated with the proportion of appendicular fat mass. Aldosterone-to-renin ratio was negatively correlated with the proportion of truncal fat mass and lean mass, and positively correlated with the proportion of appendicular fat mass.

Conclusion: Patients with PA presented significant differences in glycometabolism, fat mass, and lean mass compared with HCs, and these alterations correlated with PA progression.

References

Chen L, Lee W, Peng L, Liu L, Arai H, Akishita M . Recent Advances in Sarcopenia Research in Asia: 2016 Update From the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2016; 17(8):767.e1-7. DOI: 10.1016/j.jamda.2016.05.016. View

Moon S . Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Endocr J. 2013; 61(1):61-70. DOI: 10.1507/endocrj.ej13-0244. View

Han M, Cao X, Zhao C, Yang L, Yin N, Shen P . Assessment of Glycometabolism Impairment and Glucose Variability Using Flash Glucose Monitoring System in Patients With Adrenal Diseases. Front Endocrinol (Lausanne). 2020; 11:544752. PMC: 7546367. DOI: 10.3389/fendo.2020.544752. View

Gowri S M, Antonisamy B, Geethanjali F, Thomas N, Jebasingh F, Paul T . Distinct opposing associations of upper and lower body fat depots with metabolic and cardiovascular disease risk markers. Int J Obes (Lond). 2021; 45(11):2490-2498. DOI: 10.1038/s41366-021-00923-1. View

Er L, Lin M, Tsai Y, Hsiao J, Yang C, Chang C . Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma. BMJ Open Diabetes Res Care. 2020; 8(1). PMC: 7383952. DOI: 10.1136/bmjdrc-2019-001153. View

Kouda K, Fujita Y, Ohara K, Tachiki T, Tamaki J, Yura A . Associations between trunk-to-peripheral fat ratio and cardiometabolic risk factors in elderly Japanese men: baseline data from the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study. Environ Health Prev Med. 2021; 26(1):35. PMC: 7980554. DOI: 10.1186/s12199-021-00959-9. View

Kwak M, Lee S, Cho Y, Suh S, Kim B, Song K . The Differential Effect of Excess Aldosterone on Skeletal Muscle Mass by Sex. Front Endocrinol (Lausanne). 2019; 10:195. PMC: 6450066. DOI: 10.3389/fendo.2019.00195. View

Luther J, Wei D, Ghoshal K, Peng D, Adler G, Turcu A . Treatment of Primary Aldosteronism Increases Plasma Epoxyeicosatrienoic Acids. Hypertension. 2021; 77(4):1323-1331. PMC: 8320355. DOI: 10.1161/HYPERTENSIONAHA.120.14808. View

Goossens G . The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function. Obes Facts. 2017; 10(3):207-215. PMC: 5644968. DOI: 10.1159/000471488. View

10.

Huang W, Chen Y, Yang S, Lai C, Lai T, Chen H . Fat mass as an important predictor of persistent hypertension in patients with primary aldosteronism after adrenalectomy. Hypertens Res. 2023; 46(6):1375-1384. DOI: 10.1038/s41440-023-01203-3. View

11.

Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A . Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022; 69(4):327-359. DOI: 10.1507/endocrj.EJ21-0508. View

12.

CONN J . PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM. IMPORTANCE IN DIFFERENTIAL DIAGNOSIS AND IN RESEARCH OF ESSENTIAL HYPERTENSION. JAMA. 1964; 190:222-5. View

13.

Baudrand R, Guarda F, Torrey J, Williams G, Vaidya A . Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism. J Clin Endocrinol Metab. 2016; 101(11):3989-3996. PMC: 5095258. DOI: 10.1210/jc.2016-1963. View

14.

Monticone S, DAscenzo F, Moretti C, Williams T, Veglio F, Gaita F . Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2017; 6(1):41-50. DOI: 10.1016/S2213-8587(17)30319-4. View

15.

Chen K, Lee B, Chen P, Liu K, Lin K, Chang C . Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism. Front Endocrinol (Lausanne). 2021; 12:647184. PMC: 8323492. DOI: 10.3389/fendo.2021.647184. View

16.

Tyrovolas S, Panagiotakos D, Georgousopoulou E, Chrysohoou C, Tousoulis D, Haro J . Skeletal muscle mass in relation to 10 year cardiovascular disease incidence among middle aged and older adults: the ATTICA study. J Epidemiol Community Health. 2019; 74(1):26-31. PMC: 6929696. DOI: 10.1136/jech-2019-212268. View

17.

Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze M, Overvad K . General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008; 359(20):2105-20. DOI: 10.1056/NEJMoa0801891. View

18.

Lu Z, Tilly M, Aribas E, Bos D, Geurts S, Stricker B . Imaging-based body fat depots and new-onset atrial fibrillation in general population: a prospective cohort study. BMC Med. 2022; 20(1):317. PMC: 9484252. DOI: 10.1186/s12916-022-02505-y. View

19.

Colussi G, Catena C, Lapenna R, Nadalini E, Chiuch A, Sechi L . Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care. 2007; 30(9):2349-54. DOI: 10.2337/dc07-0525. View

20.

Hanslik G, Wallaschofski H, Dietz A, Riester A, Reincke M, Allolio B . Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry. Eur J Endocrinol. 2015; 173(5):665-75. DOI: 10.1530/EJE-15-0450. View